Free Vaccine Queue Calculator for the UK

Estimating Your Place in the UK COVID-19 Vaccine Queue

When the UK began its mass vaccination programme on 8 December 2020, millions of people immediately wondered, “When will I get the vaccine UK?” The Vaccine Queue Calculator for the UK was built to answer that question by estimating your position among the country’s priority groups. Based on the JCVI priority list UK and the latest rollout data, this free online tool lets residents of England, Scotland, Wales, and Northern Ireland see approximately how many people are ahead of them and when they might receive both doses.

The calculator uses a set of simple questions to place you in the correct priority group. These questions cover your age, whether you live or work in a care home, if you are a frontline health or social care worker, if you are clinically extremely vulnerable, whether you have an underlying health condition, if you are pregnant or planning a pregnancy, and if you are an unpaid carer. Your answers are matched against the UK vaccine priority groups defined by the Joint Committee on Vaccination and Immunisation (JCVI).

Priority Groups – Phase 1

Phase 1 (groups 1–9) focuses on saving lives and protecting the health system. The calculator assigns you to one of these groups:

Priority Group	Eligible Individuals
1	Residents and carers in care homes for older adults
2	People aged 80+ and frontline health/social care workers
3	People aged 75–79
4	People aged 70–74 and clinically extremely vulnerable individuals
5	People aged 65–69
6	People aged 16–64 with underlying health conditions that increase COVID‑19 risk, plus unpaid carers
7	People aged 60–64
8	People aged 55–59
9	People aged 50–54

Phase 2 – Age‑Based Groups

Once Phase 1 is complete, the rollout moves to three age‑only groups to keep the process simple and fast:

Priority Group	Eligible Individuals
10	People aged 40–49
11	People aged 30–39
12	People aged 18–29

The original UK government target was to offer a first dose to everyone in Phase 1 by the end of April 2021 and to finish Phase 2 by the end of July 2021. The calculator can use either the actual vaccination rate from the last seven days, the government’s planned rate, or a custom value you supply.

Who Qualifies as Clinically Extremely Vulnerable?

People in this category are moved to Group 4. You are considered clinically extremely vulnerable if you received a shielding letter from your GP or have one of the following:

• Solid organ transplant recipient.
• Specific cancers: active chemotherapy, lung cancer undergoing radical radiotherapy, blood or bone marrow cancers, immunotherapy or other antibody treatments, targeted treatments that affect the immune system (e.g., protein kinase inhibitors, PARP inhibitors), or a bone marrow/stem cell transplant within the last six months.
• Severe respiratory conditions: cystic fibrosis, severe asthma, or severe chronic obstructive pulmonary disease (COPD).
• Rare diseases that substantially increase infection risk, such as severe combined immunodeficiency (SCID) or homozygous sickle cell disease.
• Immunosuppression therapy that significantly raises infection risk.
• Asplenia (spleen removed) or splenic dysfunction.
• Down’s syndrome.
• Dialysis or chronic kidney disease stage 5.
• Pregnancy with significant congenital or acquired heart disease.
• Any other individual classed as extremely vulnerable after clinical assessment.

Underlying Health Conditions (Group 6)

If you have one of the following underlying health conditions, you are at increased risk of severe COVID‑19 and are placed in Group 6 (provided you are aged 16–64):

• Chronic respiratory disease (COPD, cystic fibrosis, severe asthma).
• Chronic heart disease or vascular disease.
• Chronic kidney disease.
• Chronic liver disease.
• Chronic neurological condition (including epilepsy).
• Down’s syndrome.
• Severe or profound learning disability (anyone on the GP learning disability register).
• Diabetes.
• Solid organ, bone marrow, or stem cell transplant recipients.
• Specific cancers (e.g., leukaemia, lymphoma, myeloma).
• Stroke or transient ischaemic attack (TIA).
• Immunosuppression from disease (such as HIV) or treatment.
• Asplenia or splenic dysfunction (e.g., sickle cell disease).
• Morbid obesity (BMI of 40 or higher).
• Severe mental illness.

The severity of your condition can affect eligibility; your GP can confirm whether you qualify.

Pregnancy, Breastfeeding, and Children

Advice for pregnant women changed in April 2021. If you are pregnant or planning a pregnancy within the next three months, you will be offered either the Pfizer‑BioNTech or Moderna vaccine. This change is supported by data from over 90,000 pregnant women vaccinated in the US with mRNA vaccines, which showed no safety concerns. Breastfeeding women can now also receive the Pfizer‑BioNTech or AstraZeneca vaccine; there is no known risk with non‑live vaccines, though you should be informed about the limited specific safety data.

Children under 16 are not routinely offered a COVID‑19 vaccine unless they face very high exposure risk and a full risk‑benefit assessment supports it. This recommendation may be updated as more trial results become available.

How the Calculator Works

Using the tool involves two sections. First, provide your personal information:

• Age (16–120). Older age moves you higher up the queue.
• Care home status – are you a resident or do you work in one?
• Frontline health or social care worker – e.g., nurse, doctor, care assistant.
• Clinically extremely vulnerable – yes if you have one of the conditions above.
• Underlying health condition – yes if you have any condition from the list.
• Pregnancy – are you pregnant or planning a pregnancy in the next three months?
• Unpaid carer – do you receive Carer’s Allowance or are you the main carer of an elderly or disabled person?

Second, adjust the rollout parameters:

• Vaccination rate – choose “Last 7 days” (actual doses per week), “UK government’s plan” (the rate needed to meet the target), or “Custom” (enter your own value or set a herd‑immunity date). Herd immunity is assumed when 70% of adults have received their second dose plus three weeks.
• Uptake rate – the default is 75% (used by the government and observed in comparable programmes). You can increase or decrease this number. For example, uptake among those over 75 has been around 93%, which shortens the queue.

The calculator then estimates:

• The minimum and maximum number of people ahead of you.
• Your priority group number (if any).
• An approximate date for your first and second doses.

Regional Variations

All four UK nations follow the same JCVI priority list, but some local adjustments have been made:

• Scotland – expanded Group 6 to include all individuals on the GP learning disability register, including those with mild or moderate learning disabilities (adding roughly 25,000 people).
• England – added 150,000 people from the learning disability register to Group 6.
• Wales and Northern Ireland – follow the standard priority list, although rollout speeds can differ due to local logistics.

Important Considerations

• The calculator’s estimates depend on the data available at the time. It was most actively updated during the first half of 2021, and policy changes such as the addition of Phase 2 groups, revised group sizes, and the shift from a 12‑week to an 8‑week second‑dose interval for those in groups 9 and below have been incorporated.
• Both doses of the vaccine are necessary for full protection. The interval between doses is typically 8–12 weeks, depending on the vaccine and current guidance.
• All vaccines authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) have passed required safety tests. Common side effects include injection‑site pain, fatigue, headache, muscle pain, and fever; these usually resolve within a few days.
• The tool is designed as a planning aid and cannot replace individual medical advice. If you have concerns about your health or vaccine eligibility, speak with a doctor.